Vineet Laboratories confirmed that its promoters have not encumbered any shares during the financial year ended March 31, 2026. The declaration, submitted to the stock exchanges, assures stakeholders that no new charges have been created on the promoter holdings, other than those previously disclosed. This compliance filing is mandatory under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to maintain transparency regarding shareholding patterns.

The disclosure was made by A Srinivasa Raju, a promoter, on behalf of all promoters and Persons Acting in Concert (PACs). The filing confirms that the group, which holds a total of 11,49,097 equity shares, has not pledged or otherwise encumbered these shares directly or indirectly during FY26. The company’s registered office is located at SY. No. 11/A3, Saheb Nagar, Kurdu Vill, Chintal Kunta, Eshwaramma Nilayam, L B Nagar, Hyderabad.

Regulatory Compliance

The declaration was submitted in accordance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to disclose any encumbrance on their holdings to ensure that the market is aware of any potential risks associated with the pledged shares. The communication was addressed to the General Manager of the Department of Corporate Services at BSE Limited and the Manager of the Listing Department at the National Stock Exchange of India Limited.

Shareholding Details

The following table outlines the key details of the shareholding covered under this declaration:

The document serves as a formal confirmation to the Audit Committee and the stock exchanges regarding the status of the promoter holdings. By confirming the absence of encumbrances, vineet laboratories provides clarity to investors concerning the financial standing of its primary shareholders.

Vineet Laboratories Limited has deferred the consideration of its audited standalone financial results for the quarter and financial year ended March 31, 2026. The Board of Directors, which met on May 30, 2026, could not take up the approval of the results as the Audit Committee had not considered or recommended them. The company will intimate the revised dates for the Audit Committee and Board meetings to the stock exchanges in due course.

The Board was informed of the resignation of the Company Secretary and Compliance Officer during the meeting held on May 30, 2026. The deferment of the financial results means the trading window for dealing in the equity shares of the company will remain closed. The window, which shut on April 01, 2026, will reopen 48 hours after the declaration of the audited standalone financial results for the quarter and financial year ended March 31, 2026.

The proceedings are governed by the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the SEBI (Prohibition of Insider Trading) Regulations, 2015. The intimation regarding the deferment was submitted to BSE Limited and National Stock Exchange of India Limited on May 30, 2026. Gaddam Venkata Ramana, Managing Director, signed the disclosure.